Apixaban versus Dalteparin for the Treatment of Acute Venous Thromboembolism in Patients with Cancer: The Caravaggio Study

Author(s):
Agnelli, G.; Becattini, C.; Bauersachs, R.; Brenner, B.; Campanini, M.; Cohen, A.; Connors, J.M.; Fontanella, A.; Gussoni, G.; Huisman, M.V. (0000-0003-1423-5348); Lambert, C.; Meyer, G.; Munoz, A.; Sousa, J.A. de; Torbicki, A.; Verso, M.; Vescovo, G.; Caravaggio Study Investigators
Published
2018
Publication type
Article / Letter to editor
venous thromboembolismcancerapixaban
Date issued
2018-09-30
Language
English
Is part of
Thrombosis and Haemostasis (2018), Vol. 118, no. 9, p. 1668-1678
hdl
1887/96127
doi
10.1055/s-0038-1668523